Experimental Sepsis Models: Advantages and Limitations
Sepsis is a major health problem that causes millions of deaths worldwide every year. Due to the complexity of its pathophysiology, there is no clear treatment method for it. Existing treatments impose an additional financial burden on the health systems of countries every year. Clinical and preclin...
Saved in:
Published in | The Eurasian journal of medicine Vol. 55; no. 1; pp. 120 - S124 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Turkey
AVES
01.12.2023
Atatürk University School of Medicine |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Sepsis is a major health problem that causes millions of deaths worldwide every year. Due to the complexity of its pathophysiology, there is no clear treatment method for it. Existing treatments impose an additional financial burden on the health systems of countries every year. Clinical and preclinical studies are continuously being conducted in order to prevent the development of sepsis, treat patients with sepsis, reduce mortality, and solve the socioeconomic problems that arise from it. However, it is not possible to directly test every study and potential new treatment in humans. Preclinical studies enable an understanding of pathophysiological events and the development of targeted therapies. For this purpose, many experimental sepsis models have been and continue to be applied. The extent to which these models can reflect the human sepsis condition is an important issue that needs to be emphasized. Each method has diferent strengths and weaknesses. Researchers should choose the most appropriate experimental model according to the characteristics of the experiments they plan and, if possible, conduct their studies on diferent models. |
---|---|
AbstractList | Sepsis is a major health problem that causes millions of deaths worldwide every year: Due to the complexity of its pathophysiology, there is no clear treatment method for it. Existing treatments impose an additional financial burden on the health systems of countries every year: Clinical and preclinical studies are continuously being conducted in order to prevent the development of sepsis, treat patients with sepsis, reduce mortality, and solve the socioeconomic problems that arise from it. However, it is not possible to directly test every study and potential new treatment in humans. Preclinical studies enable an understanding of pathophysiological events and the development of targeted therapies. For this purpose, many experimental sepsis models have been and continue to be applied. The extent to which these models can reflect the human sepsis condition is an important issue that needs to be emphasized. Each method has different strengths and weaknesses. Researchers should choose the most appropriate experimental model according to the characteristics of the experiments they plan and, if possible, conduct their studies on different models. Sepsis is a major health problem that causes millions of deaths worldwide every year: Due to the complexity of its pathophysiology, there is no clear treatment method for it. Existing treatments impose an additional financial burden on the health systems of countries every year: Clinical and preclinical studies are continuously being conducted in order to prevent the development of sepsis, treat patients with sepsis, reduce mortality, and solve the socioeconomic problems that arise from it. However, it is not possible to directly test every study and potential new treatment in humans. Preclinical studies enable an understanding of pathophysiological events and the development of targeted therapies. For this purpose, many experimental sepsis models have been and continue to be applied. The extent to which these models can reflect the human sepsis condition is an important issue that needs to be emphasized. Each method has different strengths and weaknesses. Researchers should choose the most appropriate experimental model according to the characteristics of the experiments they plan and, if possible, conduct their studies on different models. Keywords: Sepsis, experimental model, CLP LPS Sepsis is a major health problem that causes millions of deaths worldwide every year. Due to the complexity of its pathophysiology, there is no clear treatment method for it. Existing treatments impose an additional financial burden on the health systems of countries every year. Clinical and preclinical studies are continuously being conducted in order to prevent the development of sepsis, treat patients with sepsis, reduce mortality, and solve the socioeconomic problems that arise from it. However, it is not possible to directly test every study and potential new treatment in humans. Preclinical studies enable an understanding of pathophysiological events and the development of targeted therapies. For this purpose, many experimental sepsis models have been and continue to be applied. The extent to which these models can reflect the human sepsis condition is an important issue that needs to be emphasized. Each method has diferent strengths and weaknesses. Researchers should choose the most appropriate experimental model according to the characteristics of the experiments they plan and, if possible, conduct their studies on diferent models. Sepsis is a major health problem that causes millions of deaths worldwide every year. Due to the complexity of its pathophysiology, there is no clear treatment method for it. Existing treatments impose an additional financial burden on the health systems of countries every year. Clinical and preclinical studies are continuously being conducted in order to prevent the development of sepsis, treat patients with sepsis, reduce mortality, and solve the socioeconomic problems that arise from it. However, it is not possible to directly test every study and potential new treatment in humans. Preclinical studies enable an understanding of pathophysiological events and the development of targeted therapies. For this purpose, many experimental sepsis models have been and continue to be applied. The extent to which these models can reflect the human sepsis condition is an important issue that needs to be emphasized. Each method has diferent strengths and weaknesses. Researchers should choose the most appropriate experimental model according to the characteristics of the experiments they plan and, if possible, conduct their studies on diferent models.Sepsis is a major health problem that causes millions of deaths worldwide every year. Due to the complexity of its pathophysiology, there is no clear treatment method for it. Existing treatments impose an additional financial burden on the health systems of countries every year. Clinical and preclinical studies are continuously being conducted in order to prevent the development of sepsis, treat patients with sepsis, reduce mortality, and solve the socioeconomic problems that arise from it. However, it is not possible to directly test every study and potential new treatment in humans. Preclinical studies enable an understanding of pathophysiological events and the development of targeted therapies. For this purpose, many experimental sepsis models have been and continue to be applied. The extent to which these models can reflect the human sepsis condition is an important issue that needs to be emphasized. Each method has diferent strengths and weaknesses. Researchers should choose the most appropriate experimental model according to the characteristics of the experiments they plan and, if possible, conduct their studies on diferent models. |
Audience | Academic |
Author | Bekmez, Hüseyin Aydın, Pelin |
Author_xml | – sequence: 1 givenname: Pelin surname: Aydın fullname: Aydın, Pelin organization: Department of Pharmacology, Atatürk University Faculty of Medicine, Erzurum, Turkey – sequence: 2 givenname: Hüseyin surname: Bekmez fullname: Bekmez, Hüseyin organization: Department of Anesthesiology and Reanimation, Erzurum City Hospital, Erzurum, Turkey |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39109920$$D View this record in MEDLINE/PubMed |
BookMark | eNptkU1PAjEQhhuDEUT-gm7ixQvYdna7Wy-GEPxIMB7Uc1O6s1iy28XtQvTfWwMSSWwP08w8fftO55R0XO2QkAtGRwlL-DWuG-2tdssK8xGnHEYcQMRHpMeAZsMsjXlnf4a4SwbeL2lYsQTg4oR0QTIqJac9IqafK2xsha7VZfSCK2999FTnWPqbaJxvdMgv0Efa5dHMVrbVra2dPyPHhS49DnaxT97upq-Th-Hs-f5xMp4NTQysHWbIBfA5JDwrRGIKk1Im5VzKUA6RzRmyxIg0zxjGoBkA0yyPBS806FQa6JPbre5qPQ_dmmCz0aVaBce6-VK1tuqw4uy7WtQbxRhNE8qSoHC1U2jqjzX6VlXWGyxL7bBeexV-SWZZeDkN6OUWXegSlXVFHSTND67GaSaogCSNAzX6hwo7x8qaMKnChvzBhfO_PezN_w4BvgFqkY1f |
ContentType | Journal Article |
Copyright | COPYRIGHT 2023 AVES 2024 authors 2024 authors |
Copyright_xml | – notice: COPYRIGHT 2023 AVES – notice: 2024 authors 2024 authors |
DBID | NPM 7X8 5PM |
DOI | 10.5152/eurasianjmed.2023.23364 |
DatabaseName | PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1308-8742 |
EndPage | S124 |
ExternalDocumentID | A786063574 39109920 |
Genre | Journal Article |
GeographicLocations | Turkey |
GeographicLocations_xml | – name: Turkey |
GroupedDBID | 3V. 53G 7RQ 7X7 8FI 8R4 8R5 AAWTL ABDBF ADBBV AFKRA AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS BAWUL BENPR BPHCQ BVXVI DIK EDSIH EOJEC ESX FYUFA GROUPED_DOAJ HYE IAO IHR INH INR ITC MK0 NPM OBODZ PIMPY PQQKQ PROAC Q2X RNS RPM TUS 7X8 5PM |
ID | FETCH-LOGICAL-c431t-8e2632b3528f65cfc70199b99c4399b1b1e15c67d81e43a1331a1d462fa3a79c3 |
IEDL.DBID | RPM |
ISSN | 1308-8734 |
IngestDate | Tue Sep 17 21:29:25 EDT 2024 Sat Oct 26 04:26:40 EDT 2024 Wed Mar 27 18:02:05 EDT 2024 Tue Mar 26 04:58:51 EDT 2024 Tue Oct 29 09:18:46 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c431t-8e2632b3528f65cfc70199b99c4399b1b1e15c67d81e43a1331a1d462fa3a79c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Cite this article as: Aydın P, Bekmez H. Experimental sepsis models: Advantages and limitations. Eurasian J Med., 2023;55(Suppl. Issue: 1):S120-S124. |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11075015/ |
PMID | 39109920 |
PQID | 3089881337 |
PQPubID | 23479 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11075015 proquest_miscellaneous_3089881337 gale_infotracmisc_A786063574 gale_infotracacademiconefile_A786063574 pubmed_primary_39109920 |
PublicationCentury | 2000 |
PublicationDate | 2023-12-01 |
PublicationDateYYYYMMDD | 2023-12-01 |
PublicationDate_xml | – month: 12 year: 2023 text: 2023-12-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Turkey |
PublicationPlace_xml | – name: Turkey |
PublicationTitle | The Eurasian journal of medicine |
PublicationTitleAlternate | Eurasian J Med |
PublicationYear | 2023 |
Publisher | AVES Atatürk University School of Medicine |
Publisher_xml | – name: AVES – name: Atatürk University School of Medicine |
SSID | ssj0000493326 |
Score | 2.305062 |
Snippet | Sepsis is a major health problem that causes millions of deaths worldwide every year. Due to the complexity of its pathophysiology, there is no clear treatment... Sepsis is a major health problem that causes millions of deaths worldwide every year: Due to the complexity of its pathophysiology, there is no clear treatment... |
SourceID | pubmedcentral proquest gale pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 120 |
SubjectTerms | Anesthesiology and Reanimation Biological models Methods Review Sepsis |
Title | Experimental Sepsis Models: Advantages and Limitations |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39109920 https://www.proquest.com/docview/3089881337 https://pubmed.ncbi.nlm.nih.gov/PMC11075015 |
Volume | 55 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fS8MwED7UB_FF_O38RQXBp25Lk6aJbyIbIkwEFXwrSZrixNVht__fu3ST1Uefk0B6_Zq7a777DuBKlKqvCpXGpZZlLHiSxtZKHfedTAx6XOUZFTiPHuX9q3h4S9_WQC5rYQJp39lxt_qcdKvxe-BWTieut-SJ9Z5Gd5SzpOjHeuuwjghdydE_mpiX89BnDc9nhZ87Fw2xC1130vPz71Ce-IHOpku9w7sJ56Q38PdEXnFJbbrkiv8Z7sD2InCMbpsN7sKar_Zgc7S4Gt8HOVjR6o-e_bQe1xF1Ovusb6LQO3mGR0cdmaqIQlVT86vuAF6Hg5e7-3jRFCF26OtnsfKksG5JlKWUqSsd6alrq7WjzMIyyzxLncwKxbzgBlNQZlghZFIabjLt-CFsVF-VP4bIC6eZ8NyUWSKs8MZmQlqTGo9RQcFcB67JJjlBHR_cmQVjH1eTaFR-mylMf3iaiQ6ctWYiRF1r-HJp1ZyGiNdV-a95neML0krhJrMOHDVWzqeNzEbONd3aJf0OqJb9fyeQMnZ7BAETFLKXADn5_9JT2CJ0NMyVM9iYfc_9OcYfM3sR8vaLALoftMvbpg |
link.rule.ids | 230,315,730,783,787,867,888,27938,27939,53806,53808 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwEB1RKrVcaGkLLOUjlSr1lOw6dhybG0KgpWVRpYLKLbIdR10KYUWyF349M8mm2nAr57ElxzP2zMRv3gB8FYUaqVwlYaFlEQoeJ6G1UocjJ2ODHld5RgXOkws5vhLfr5PrFZBdLUwD2nd2GpW3d1E5_dNgK2d3btjhxIY_J8eUsyTox4av4DUe2JFcytJv2qiX86bTGt7QCg88Fy20C513PPTzh6ZA8QbdTUTdw6OYc2IceH4nLzmlPmByyQOdvoPf3dpb4MnfaF7byD0-o3X8_497D-uLoDQ4auUbsOLLD_Bmsnh2_wjyZKkPQPDLz6ppFVAXtdvqMGj6Mtd4LVWBKfOgqZhqfwN-gqvTk8vjcbhouBA6jCPqUHlib7dE-FLIxBWOuNq11dpR1mKZZZ4lTqa5Yl5wg-ktMywXMi4MN6l2fBNWy_vSb0PghdNMeG6KNBZWeGNTIa1JjMeII2duAN9otzM6RrilziyqAXA2EVJlR6nC1IonqRjAbm8kmr_rib90-spIRJix0t_PqwxVr5XCRaYD2Gr1l81aCo-Ma3oRjEcDUD3N_htArNt9CeqrYd_u9LPz8qkH8HZ8OTnPzs8ufnyGNbLBFiGzC6v1w9zvYZxT2_3GqJ8Ag7T8zg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4BlRCXlr7otkBTqVJPSdax49jcELCCtouQWiSkHiLbccRSCCuSvfTXdybJog1HzrYlx-N5xd98A_BVlGqsCpWGpZZlKHiShtZKHY6dTAx6XOUZFThPz-Xppfh-lV71qMq6h1VWzs6i6vYuqmbXLbZyfufiJU4svpgeUc6Soh-L50UZr8MLVNqxWsnUb7rIl_O22xpaaYVKz0UH70IHnsR-8dAWKd6gy4mog3iUcE6sA0_t8opjGoImV7zQ5BX8We6_A5_8jRaNjdy_J9SOz_vAbXjZB6fBYTfnNaz56g1sTvvn97cgT1b6AQS__Lye1QF1U7utD4K2P3OD5qkOTFUEbeVU9zvwHVxOTn4fnYZ944XQYTzRhMoTi7sl4pdSpq50xNmurdaOshfLLPMsdTIrFPOCG0xzmWGFkElpuMm04-9ho7qv_AcIvHCaCc9NmSXCCm9sJqQ1qfEYeRTMjeAbnXhO6oTH6kxfFYCriZgqP8wUplg8zcQIdgczUQ3cYPjLUmY5DRF2rPL3izpH8WulcJPZCHY6Gebzjsoj55peBpPxCNRAuo8TiH17OIIya1m4lzL6-Pyln2Hz4niS_zw7__EJtugadkCZXdhoHhZ-D8Odxu639_o_fID_Tg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Experimental+Sepsis+Models%3A+Advantages+and+Limitations&rft.jtitle=The+Eurasian+journal+of+medicine&rft.au=Ayd%C4%B1n%2C+Pelin&rft.au=Bekmez%2C+H%C3%BCseyin&rft.date=2023-12-01&rft.issn=1308-8734&rft.volume=55&rft.issue=1&rft.spage=120&rft_id=info:doi/10.5152%2Feurasianjmed.2023.23364&rft_id=info%3Apmid%2F39109920&rft.externalDocID=39109920 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1308-8734&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1308-8734&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1308-8734&client=summon |